Immunopharmacology.

Geza T Terezhalmy, S. J. Esposito, G. S. Safadi

Research output: Contribution to journalArticle

Abstract

Clinicians, in general, must understand the basis of immunomodulation; management principles associated with organ transplantation, autoimmune diseases, and allergic reactions; and complications of therapy. They must recognize that these patients require multidisciplinary treatment and coordination of care. Oral health care providers must recognize that immunotherapy may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and respond to the obligation to deliver quality care, competently and timely before, during, and after immunotherapy.

Original languageEnglish (US)
Pages (from-to)685-707
Number of pages23
JournalDental Clinics of North America
Volume40
Issue number3
StatePublished - Jul 1996
Externally publishedYes

Fingerprint

Immunotherapy
Immunomodulation
Quality of Health Care
Oral Health
Organ Transplantation
Health Personnel
Autoimmune Diseases
Hypersensitivity
Therapeutics

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Terezhalmy, G. T., Esposito, S. J., & Safadi, G. S. (1996). Immunopharmacology. Dental Clinics of North America, 40(3), 685-707.

Immunopharmacology. / Terezhalmy, Geza T; Esposito, S. J.; Safadi, G. S.

In: Dental Clinics of North America, Vol. 40, No. 3, 07.1996, p. 685-707.

Research output: Contribution to journalArticle

Terezhalmy, GT, Esposito, SJ & Safadi, GS 1996, 'Immunopharmacology.', Dental Clinics of North America, vol. 40, no. 3, pp. 685-707.
Terezhalmy GT, Esposito SJ, Safadi GS. Immunopharmacology. Dental Clinics of North America. 1996 Jul;40(3):685-707.
Terezhalmy, Geza T ; Esposito, S. J. ; Safadi, G. S. / Immunopharmacology. In: Dental Clinics of North America. 1996 ; Vol. 40, No. 3. pp. 685-707.
@article{d15015fce5aa4f798d346c49fa1afa4c,
title = "Immunopharmacology.",
abstract = "Clinicians, in general, must understand the basis of immunomodulation; management principles associated with organ transplantation, autoimmune diseases, and allergic reactions; and complications of therapy. They must recognize that these patients require multidisciplinary treatment and coordination of care. Oral health care providers must recognize that immunotherapy may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and respond to the obligation to deliver quality care, competently and timely before, during, and after immunotherapy.",
author = "Terezhalmy, {Geza T} and Esposito, {S. J.} and Safadi, {G. S.}",
year = "1996",
month = "7",
language = "English (US)",
volume = "40",
pages = "685--707",
journal = "Dental Clinics of North America",
issn = "0011-8532",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Immunopharmacology.

AU - Terezhalmy, Geza T

AU - Esposito, S. J.

AU - Safadi, G. S.

PY - 1996/7

Y1 - 1996/7

N2 - Clinicians, in general, must understand the basis of immunomodulation; management principles associated with organ transplantation, autoimmune diseases, and allergic reactions; and complications of therapy. They must recognize that these patients require multidisciplinary treatment and coordination of care. Oral health care providers must recognize that immunotherapy may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and respond to the obligation to deliver quality care, competently and timely before, during, and after immunotherapy.

AB - Clinicians, in general, must understand the basis of immunomodulation; management principles associated with organ transplantation, autoimmune diseases, and allergic reactions; and complications of therapy. They must recognize that these patients require multidisciplinary treatment and coordination of care. Oral health care providers must recognize that immunotherapy may produce adverse effects by direct toxicity at the cellular level or indirectly, characterized by myeloimmunosuppression, and respond to the obligation to deliver quality care, competently and timely before, during, and after immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0030185840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030185840&partnerID=8YFLogxK

M3 - Article

C2 - 8829051

AN - SCOPUS:0030185840

VL - 40

SP - 685

EP - 707

JO - Dental Clinics of North America

JF - Dental Clinics of North America

SN - 0011-8532

IS - 3

ER -